Src family kinases differentially influence glioma growth and motility

Laura J. Lewis‐Tuffin(Mayo Clinic in Florida), Panos Z. Anastasiadis(Mayo Clinic in Florida)

Molecular Oncology

June 10, 2015

10.1016/j.molonc.2015.06.001

Cited by 61

Related Papers

Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion

|PLoS ONE|2013|77

Cadherins and catenins in cancer: connecting cancer pathways and tumor microenvironment

|Frontiers in Cell and Developmental Biology|2023|44

A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma

|JCI Insight|2023|8

PLEKHA7, an apical adherens junction protein, suppresses inflammatory breast cancer in the context of high E-cadherin and p120-catenin expression.

|Research Square|2020|2